International Journal of Radiation Oncology Biology Physics Q1 Unclaimed

Elsevier Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

International Journal of Radiation Oncology Biology Physics is a journal indexed in SJR in Oncology and Cancer Research with an H index of 248. It is an CC BY-NC-ND Journal with a Double blind Peer Review review system The scope of the journal is focused on Cancer, Radiation Oncology, Oncology, Medical Physics. It has an SJR impact factor of 2,117 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,117.

International Journal of Radiation Oncology Biology Physics focuses its scope in these topics and keywords: cancer, radiation, therapy, radiotherapy, prostate, patients, cell, lung, treatment, treated, ...

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

International Journal of Radiation Oncology Biology Physics

2,117

SJR Impact factor

248

H Index

584

Total Docs (Last Year)

1807

Total Docs (3 years)

14085

Total Refs

6588

Total Cites (3 years)

1167

Citable Docs (3 years)

3,48

Cites/Doc (2 years)

24,12

Ref/Doc

Aims and Scope


cancer, radiation, therapy, radiotherapy, prostate, patients, cell, lung, treatment, treated, breast, stereotactic, proton, dose, prospective, nonsmall, irradiation, study, outcome, prognostic, quality, Cancer, Radiation Oncology, Oncology, Medical Physics



Best articles by citations

High-speed magnetic resonance imaging for four-dimensional treatment planning of conformal radiotherapy of moving body tumors

View more

Conformal radiotherapy for paranasal sinus and nasal cavity tumors: three-dimensional treatment planning and preliminary results in 40 patients

View more

76 Neuropsychological function in adults after high dose fractionated radiation therapy of skull base sarcomas

View more

408 Radiotherapy for pediatric brain tumors standards of care, current clinical trials, and new directions

View more

The external radiotherapy with three-dimensional conformal boost after the neoadjuvant androgen suppression for patients with locally advanced prostatic carcinoma

View more

161 Prolonged G2 delay in murine lymphoma cells susceptible to radiation-induced apoptosis correlates with cyclin B1 expression

View more

60 Identification and characterization of the gene responsible for the radiosensitive phenotype of scid mice

View more

Toward optimal external-beam fractionation for prostate cancer

View more

Three-dimensional small-volume irradiation for residual or recurrent nasopharyngeal carcinoma

View more

Blood hemoglobin level may affect radiosensitivity - preliminary results on acutely reacting normal tissues

View more

Concomitant boost radiation therapy for inoperable non-small-cell lung cancer: preliminary report of a prospective randomized study

View more

10 Prognostic factors associated with radiosurgery for malignant glioma: Results of a multi institutional Gamma Knife study

View more
SHOW MORE ARTICLES

In response to Dr. Yaes

View more

In response to Drs. Mehrkens, Stummer, and Kreth

View more

In response to Drs. Rousseau and Gibon

View more

In response to Drs. Vaarkamp and Zhu

View more

In response to Drs. Wilson and Lim

View more

Optimizing for the Gamma Knife

View more

Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells

View more

26 Quantification of regional lung injury with serial spect lung perfusion imaging

View more

64 evaluation of a gene therapy system using a replication competent, non-neurovirulent HSV-1 viral vector used tn combination with radiotherapy

View more

Intensity-modulated radiotherapy: rethinking basic treatment planning paradigms

View more

A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404

View more

52 A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous bone metastases-RTOG 88-22

View more

Comments

No comments ... Be the first to comment!

FAQS